ERAS
Biotechnology · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Erasca, Inc. publishes a filing, an earnings call transcript or a press release.
Get ERAS alertsDavid Chacko is recorded as CFO at Erasca, Inc. (ERAS). The newest filing on record that lists David Chacko as CFO at Erasca, Inc. (ERAS) is dated April 28, 2026. The proxy statement of Erasca, Inc. reports total compensation of $1,778,496 for David Chacko in fiscal 2025, including a base salary of $516,700. Disclosed compensation is on record for 4 fiscal years. David Chacko has spoken on 1 earnings call and 3 other investor events across 1 company, most recently for Erasca, Inc. on November 18, 2026. Erasca, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Erasca, Inc. includes Jonathan Lim (CEO), Ebun S. Garner (General Counsel), Alexander W. Casdin (Board Member) and 7 others.
“Yeah, so we just announced yesterday evening a collaboration with BMS for NABLI metastat, their PRMT5 inhibitor, and we had previously announced a collaboration with Tango for Vopi metastat.”
“So the Borealis I study is our pan-KRAS inhibitor study. We have guided to the fact that we'll have a phase one dose escalation update in the second half of this year.”
“Mid-Cap Biotech Equity Research at Morgan Stanley, and welcome to the Morgan Stanley Global Healthcare Conference.”
“Yes, Chris, we completed a $45 million oversubscribed private placement with high-quality investors. This financing secured our runway out to the second half of 2026, compared to the previous guidance of the first half of 2026.”
Start not stated–present
Last confirmed April 28, 2026
ERAS
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Erasca, Inc. (ERAS) | Chief Financial Officer and Chief Business Officer | $516,700 | $1,778,496 |
| 2024 | Erasca, Inc. (ERAS) | Chief Financial Officer and Chief Business Officer | $492,100 | $1,884,506 |
| 2023 | Erasca, Inc. (ERAS) | Chief Financial Officer and Chief Business Officer | $475,500 | $2,433,990 |
| 2022 | Erasca, Inc. (ERAS) | Chief Financial Officer and Chief Business Officer | $440,300 | $3,663,803 |